Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Head and Neck Cancer
Interventions
DEVICE

bandage skin Hydrotac®

Patients randomized to the arm with bandage skin will benefit from the application of the bandage skin hydrogel (Hydrotac®) at least 5 hours per day for the duration of treatment (the first day last day of radiotherapy).

DRUG

Ialuset®

Patients randomized to receive reference of the application of cervical Ialuset® on skin throughout the treatment period (the first day to last day of radiotherapy).

Trial Locations (7)

14000

Centre Maurice TUBIANA, Caen

14033

CHU, Caen

14076

Centre François BACLESSE, Caen

37000

Clinique Leonard de Vinci, Chambray-lès-Tours

76000

Centre Guillaume Le Conquérant, Le Havre

Unknown

Centre de la Baie, Avranches

centre hospitalier du Cotentin, Cherbourg

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

lead

Centre Francois Baclesse

OTHER

NCT01520701 - Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy | Biotech Hunter | Biotech Hunter